3:47 PM ET
10-Q
Financial Results
United Health Products Q3 2026 Results: Net Loss of $185K, Loss Narrows
United Health Products, Inc. reported zero revenue for the nine months ended September 30, 2026, as it continues to seek regulatory approval for its CelluSTAT hemostatic gauze. The company recorded a net loss of $785,250 for the period, a significant improvement from the $2,150,775 loss in the prior year, primarily due to reduced selling, general, and administrative expenses.
- Key figure
- Net loss $185K